Gemeniano, Hermenio Jr F.

HRN: 27-82-14  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/11/2026
08/18/2026
IV
500
Q8
Infectious Diarrhea
Checking Initial Appropriateness 
08/11/2026
CEFTRIAXONE 1G (VIAL)
08/11/2026
08/18/2026
IV
2g
Q24
CAP MR
Checking Initial Appropriateness 
08/11/2026
AZITHROMYCIN 500MG TABLET (TAB)
08/11/2026
08/14/2026
ORAL
500
OD
CAP MR
Checking Initial Appropriateness 
08/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/13/2026
08/20/2026
IV
1g
Q72
K Pneumoniae Carbapenemase Producing
Remove - Pending Acceptance
08/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/13/2026
08/20/2026
IV
500mg
Q48h
CAP-MR- Klebsiella Pneumoniae
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: